Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma

Show other versions (1)
Bibliographic Details
Main Authors: Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco‐Aparicio, Cristian Garcia‐Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer vonStedingk, Daniel Bexell
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:EMBO Molecular Medicine
Online Access:https://doi.org/10.15252/emmm.201911749
id doaj-45d12cad1ecf49c5889356105e3e973f
record_format Article
spelling doaj-45d12cad1ecf49c5889356105e3e973f2021-08-02T18:00:29ZengWileyEMBO Molecular Medicine1757-46761757-46842020-01-01121n/an/a10.15252/emmm.201911749Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastomaSofie MohlinKarin HanssonKatarzyna RadkeSonia MartinezCarmen Blanco‐AparicioCristian Garcia‐RuizCharlotte WelinderJavanshir EsfandyariMichael O'NeillJoaquin PastorKristoffer vonStedingkDaniel Bexellhttps://doi.org/10.15252/emmm.201911749
collection DOAJ
language English
format Article
sources DOAJ
author Sofie Mohlin
Karin Hansson
Katarzyna Radke
Sonia Martinez
Carmen Blanco‐Aparicio
Cristian Garcia‐Ruiz
Charlotte Welinder
Javanshir Esfandyari
Michael O'Neill
Joaquin Pastor
Kristoffer vonStedingk
Daniel Bexell
spellingShingle Sofie Mohlin
Karin Hansson
Katarzyna Radke
Sonia Martinez
Carmen Blanco‐Aparicio
Cristian Garcia‐Ruiz
Charlotte Welinder
Javanshir Esfandyari
Michael O'Neill
Joaquin Pastor
Kristoffer vonStedingk
Daniel Bexell
Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
EMBO Molecular Medicine
author_facet Sofie Mohlin
Karin Hansson
Katarzyna Radke
Sonia Martinez
Carmen Blanco‐Aparicio
Cristian Garcia‐Ruiz
Charlotte Welinder
Javanshir Esfandyari
Michael O'Neill
Joaquin Pastor
Kristoffer vonStedingk
Daniel Bexell
author_sort Sofie Mohlin
title Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
title_short Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
title_full Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
title_fullStr Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
title_full_unstemmed Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
title_sort anti‐tumor effects of pim/pi3k/mtor triple kinase inhibitor ibl‐302 in neuroblastoma
publisher Wiley
series EMBO Molecular Medicine
issn 1757-4676
1757-4684
publishDate 2020-01-01
url https://doi.org/10.15252/emmm.201911749
work_keys_str_mv AT sofiemohlin antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT karinhansson antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT katarzynaradke antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT soniamartinez antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT carmenblancoaparicio antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT cristiangarciaruiz antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT charlottewelinder antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT javanshiresfandyari antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT michaeloneill antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT joaquinpastor antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT kristoffervonstedingk antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
AT danielbexell antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma
_version_ 1721228537244942336

Similar Items